Cargando…
Autocrine motility factor receptor as a therapeutic target for asthma: comments on ‘AMFR drives allergic asthma development by promoting alveolar macrophage-derived GM-CSF production’
Autores principales: | Zhang, Huihui, Qian, Feng, Sun, Lei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9412747/ https://www.ncbi.nlm.nih.gov/pubmed/35561732 http://dx.doi.org/10.1093/jmcb/mjac032 |
Ejemplares similares
-
AMFR drives allergic asthma development by promoting alveolar macrophage–derived GM-CSF production
por: Zhang, Huihui, et al.
Publicado: (2022) -
GM-CSF and IL-33 Orchestrate Polynucleation and Polyploidy of Resident Murine Alveolar Macrophages in a Murine Model of Allergic Asthma
por: Quell, Katharina M., et al.
Publicado: (2020) -
Chemokine CCL1 as a therapeutic target for pulmonary fibrosis: comments on ‘The chemokine CCL1 triggers an AMFR‒SPRY1 pathway that promotes differentiation of lung fibroblasts into myofibroblasts and drives pulmonary fibrosis’
por: Liu, Shanshan, et al.
Publicado: (2021) -
Betulinic Acid Exerts Cytotoxic Activity Against Multidrug-Resistant Tumor Cells via Targeting Autocrine Motility Factor Receptor (AMFR)
por: Saeed, Mohamed E. M., et al.
Publicado: (2018) -
Loss of GM-CSF-dependent instruction of alveolar macrophages in COVID-19 provides a rationale for inhaled GM-CSF treatment
por: Bosteels, Cedric, et al.
Publicado: (2022)